Aristides Capital LLC Acquires 14,641 Shares of Genpact Limited (NYSE:G)

Aristides Capital LLC raised its stake in Genpact Limited (NYSE:G) by 21.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,133 shares of the business services provider’s stock after acquiring an additional 14,641 shares during the quarter. Genpact makes up approximately 0.7% of Aristides Capital LLC’s investment portfolio, making the stock its 18th largest position. Aristides Capital LLC’s holdings in Genpact were worth $3,528,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Grantham Mayo Van Otterloo & Co. LLC bought a new position in Genpact in the 4th quarter valued at approximately $790,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Genpact during the fourth quarter worth $324,000. Wells Fargo & Company MN lifted its stake in shares of Genpact by 35.4% in the 4th quarter. Wells Fargo & Company MN now owns 16,838 shares of the business services provider’s stock valued at $723,000 after acquiring an additional 4,403 shares during the last quarter. Integrated Quantitative Investments LLC acquired a new stake in shares of Genpact during the 4th quarter valued at $812,000. Finally, Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock worth $26,000 after acquiring an additional 216 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Genpact Trading Down 3.7 %

NYSE:G opened at $47.08 on Friday. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The firm’s fifty day moving average is $51.20 and its 200-day moving average is $45.44. The firm has a market cap of $8.27 billion, a P/E ratio of 16.58, a P/E/G ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:G) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact’s payout ratio is presently 23.94%.

Analyst Upgrades and Downgrades

Several research firms have commented on G. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Needham & Company LLC lifted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $48.44.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.